Clinical Trials Logo
  1. Home
  2. Rate of Angina
  3. NCT02455817
  4. Details
NCT02455817 Clinical Trial

REWARDS-Angina at Follow up Post Stenting

Rate of Angina Clinical Trial

Official title:
REWARDS-Angina at Follow up Post Stenting

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT02455817
Other study ID # REWARDS- Angina
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date June 2015
Est. completion date June 2016

Study information
Verified date June 2018
Source Medstar Health Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Single center, retrospective registry to collect data regarding the rate of angina (any and CCS clas III/IV) within 12 months post stent implantation. In addition, the target vessel revascularization rate within 12 months post stent implantation.

Description:

The objective of this study is to retrospectively identify the rate of angina (any as well as CCS class III/IV) up to one (1) year following stent implantation. The following drug eluting stents will be evaluated in addition to bare metal stents; Cypher, Taxus Express, Xience V, Resolute and Promus Element. The target vessel revascularization rate will also be compared for the 6 stent types within one (1) year.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients, male or female, > 18 years of age,

- Patients who received at least one (1) commercially available Drug Eluting Stent or Bare Metal Stent: Cypher, Taxus Express, Xience V, Promus Element, Resolute, or Bare Metal Stents

Exclusion Criteria:

- Received more than one type of DES as listed above or both a BMS and DES (as listed above)

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Medstar Health Research Institute

Outcome
Type Measure Description Time frame Safety issue
Primary Rate of Angina post PCI for a variety of DES and BMS up to 1 year